Nasal Glucagon + Intramuscular Glucagon
Phase 3Completed 1 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Diabetes Mellitus, Type 1
Conditions
Diabetes Mellitus, Type 1
Trial Timeline
Nov 1, 2013 → Jan 1, 2015
NCT ID
NCT01994746About Nasal Glucagon + Intramuscular Glucagon
Nasal Glucagon + Intramuscular Glucagon is a phase 3 stage product being developed by Eli Lilly for Diabetes Mellitus, Type 1. The current trial status is completed. This product is registered under clinical trial identifier NCT01994746. Target conditions include Diabetes Mellitus, Type 1.
What happened to similar drugs?
20 of 20 similar drugs in Diabetes Mellitus, Type 1 were approved
Approved (20) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
17
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03339453 | Phase 1 | Completed |
| NCT01994746 | Phase 3 | Completed |
| NCT01997411 | Phase 2/3 | Completed |
Competing Products
20 competing products in Diabetes Mellitus, Type 1